Deerfield Management Company, L.P. (Series C) ALNYLAM PHARMACEUTICALS INC Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
Number of Shares
110,000,000
Previous 100,000,000
10.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%